ICER's Version of HTA Is Positioned to Guide U.S. Health Care Reform
No funding supported the writing of this letter. The author is an unpaid member of the ICER Methods Advisory Committee and has participated in discussions at ICER meetings and meetings of the New England Comparative Effectiveness Advisory Council (CEPAC).
Gespeichert in:
Veröffentlicht in: | Journal of managed care & specialty pharmacy 2020-09, Vol.26 (9), p.1171-1171 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | No funding supported the writing of this letter. The author is an unpaid member of the ICER Methods Advisory Committee and has participated in discussions at ICER meetings and meetings of the New England Comparative Effectiveness Advisory Council (CEPAC). |
---|---|
ISSN: | 2376-0540 2376-1032 |
DOI: | 10.18553/jmcp.2020.26.9.1171 |